413 studies found for:    Open Studies | Exclude Unknown | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
1 Recruiting Study to Examine the Effects of MultiStem in Ischemic Stroke
Condition: Ischemic Stroke
Interventions: Biological: MultiStem;   Biological: Placebo
2 Recruiting A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke From Large Vessel Occlusion
Interventions: Device: Penumbra System with Separator 3D;   Device: Penumbra System alone
3 Not yet recruiting Safety Evaluation of 3K3A-APC in Ischemic Stroke
Condition: Ischemic Stroke
Interventions: Biological: 3K3A-APC;   Drug: Placebo
4 Recruiting Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
Condition: Stroke
Interventions: Drug: Desmoteplase;   Drug: Placebo
5 Recruiting Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Condition: Stroke
Interventions: Drug: GM602;   Drug: Matching Placebo (Bacteriostatic Saline) for GM602
6 Recruiting [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Conditions: Acute Ischaemic Stroke;   Transient Ischaemic Attack.
Interventions: Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
7 Recruiting Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Conditions: Ischemic Stroke;   Malignant Edema
Intervention: Drug: RP-1127 (Glyburide for Injection)
8 Recruiting Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Biological: BG00002 (Natalizumab);   Drug: Placebo
9 Recruiting Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window
Condition: Ischemic Stroke
Interventions: Device: The Ischemic Stroke System;   Device: Sham control
10 Recruiting AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Conditions: Stroke;   Cerebrovascular Accident;   Hemiparesis
Intervention: Device: AMES- Leg therapy
11 Recruiting Stroke Feasibility Study
Conditions: Atrial Fibrillation;   AFib
Intervention: Device: AtriClip LAA Exclusion Device
12 Recruiting Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
Conditions: AtrioVentricular Nodal Reentrant Tachycardia;   Supraventricular Tachycardia;   Heart Disease
Intervention: Device: Freezor Xtra Cryoablation Catheter
13 Recruiting A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
Condition: Ischemic Stroke
Intervention: Biological: Allogeneic adult mesenchymal bone marrow stem cells
14 Recruiting BioFreedom US IDE Feasibility Trial
Conditions: Ischemic Heart Disease;   Stable Angina;   Unstable Angina;   Silent Ischemia
Intervention: Device: BioFreedom drug coated coronary stent
15 Recruiting A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
Conditions: Heart Failure;   Respiratory Insufficiency;   Stroke Acute;   Infectious Diseases;   Rheumatic Diseases
Interventions: Drug: Rivaroxaban, 10 mg;   Drug: Rivaroxaban, 7.5 mg;   Drug: Placebo
16 Recruiting Safety of Intravenous Thrombolysis for Wake-up Stroke
Condition: Ischemic Stroke
Intervention: Drug: Alteplase (iv t-PA)
17 Recruiting Safety of Intravenous Thrombolytics in Stroke on Awakening
Condition: Stroke
Intervention: Drug: rt-PA
18 Recruiting The Fibrin Pad CV Phase III Study
Condition: Cardiovascular Disease
Interventions: Biological: EVARREST™ Fibrin Sealant Patch;   Biological: Topical hemostat
19 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
20 Recruiting The Evaluation Of PF-04950615 (RN316) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years